Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...

An unusual public feud between the Food and Drug Administration and a maker of gene therapies for rare diseases could test ...

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and Drug Administration request to stop selling a drug tied to three deaths.

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Staff from the the University of Minnesota’s Raptor Center will present free programs about birds of prey 10:30 a.m. and noon ...

Gaza saw its deadliest day yet for aid-seekers in over 21 months of war as more than 80 Palestinians were killed while trying ...

While the North Chicago, Illinois-based healthcare giant estimated its adjusted diluted earnings per share for Q3 could reach $1.28 - $1.32 compared to $1.33 in the consensus, its full-year outlook ...

Resorts in Spain and Portugal are the most popular destinations for UK holidaymakers this summer, according to a new report.

Emirati conglomerate Al-Futtaim is to buy a 49.95 percent stake in Saudi Arabian franchiser Cenomi Retail in a deal worth ...

Andy Byron resigned from his job as CEO of Astronomer Inc., according to a statement posted on LinkedIn by the company ...

The Burnside Plantation was filled with everything blueberry. Blueberry pie, blueberry ice cream. We even spoke with one guy ...